Related by context. All words. (Click for frequent words.) 70 immunotherapy 67 Autoimmune Diseases 65 Chemoprevention 64 Aliskiren 64 Immunotherapeutic 64 Cancer Vaccines 64 Small Molecule 63 Anthracycline 63 Disease Progression 63 RNAi Therapeutics 62 Malignancies 62 Cetrorelix 62 Denufosol 62 Monoclonal Antibodies 62 Bortezomib 62 Radioimmunotherapy 62 Sipuleucel T 62 Combination Therapy 62 Blinatumomab 62 Hepatocellular Carcinoma 62 Therapeutic Vaccine 62 RNAi Therapeutic 62 Monoclonal Antibody 62 Apoptosis 61 Gleevec resistant 61 Inflammatory Arthritis 61 Melphalan 61 Autoimmune Disease 61 Immune Mediated 61 Novel Antibiotic 61 Immunotherapies 61 Dendritic Cells 61 Replacement Therapy 61 Intravesical 61 Trastuzumab 61 cancer immunotherapy 61 Factor Receptor 61 Interferon 61 Intranasal 61 Phase 2a Clinical Trial 61 Talabostat 61 Decitabine 61 Kinase Inhibitors 61 Antiangiogenic 61 Treating Chronic 61 Transdermal Delivery 61 Phase 2b Clinical Trial 61 Imatinib 61 Tyrosine Kinase Inhibitor 60 Phase 2b Trial 60 Clinical Trial Results 60 Neuroprotection 60 Kinase Inhibitor 60 Romidepsin 60 Chronic Myeloid Leukemia 60 Antiviral Therapy 60 Nilotinib 60 Cisplatin 60 Omacetaxine 60 Hepatitis C Virus 60 Immune Responses 60 Mucosal 60 RNA Interference 60 Preclinical Studies 60 Antigen Specific 60 Aptamer 60 Atopic Dermatitis 60 Metabolic Disease 60 Personalized Immunotherapy 60 Autoimmunity 60 Dasatinib 60 GW# [003] 60 Antisense 60 Sapacitabine 60 Systemic Delivery 60 Antiviral 60 Anti Tumor Activity 60 Cancer Immunotherapy 60 Universal Flu Vaccine 60 IL# PE#QQR 60 Gefitinib 60 Hsp# Inhibitor 60 Pertuzumab 60 Tyrosine Kinase Inhibitors 60 Therapeutic Antibody 60 Oncogene 60 Immunotherapeutics 60 Novel Therapeutic 60 Vaccine Adjuvant 60 Oncolytic 60 Bladder Cancer 60 Demonstrates Efficacy 59 Low Dose 59 Drug Candidate 59 Anti Tumor 59 Unresectable 59 Fabry Disease 59 targeting CD# 59 Epidermal Growth Factor Receptor 59 Safinamide 59 Oncolytic Reovirus 59 Cancer Therapies 59 Therapeutic Potential 59 Corticosteroids 59 immunotoxin 59 immunotoxins 59 Phase III Trial 59 Bosutinib 59 Investigational Compound 59 Temsirolimus 59 Bendamustine 59 Topical Treatment 59 Enzastaurin 59 Metastatic Melanoma 59 Chemokine Receptor 59 Antibody Discovery 59 Bazedoxifene 59 Irinotecan 59 CEQ# 59 Myelodysplastic Syndromes 59 HDAC Inhibitor 59 Ustekinumab 59 Cyclophosphamide 59 Vaccine Candidate 59 Inflammatory Diseases 59 Malignant Melanoma 59 Golimumab 59 Adjuvant Treatment 59 selective inhibition 59 Abatacept 59 NPC 1C 59 Oral Fingolimod 59 pan HDAC inhibitor 59 Well Tolerated 59 oral prodrug 59 Cutaneous T 59 Alemtuzumab 59 Aurora Kinase 59 Bavituximab 59 Prostatic 59 Therapeutic Vaccines 59 YONDELIS 59 Archexin 59 Tumor Targeting 59 Hydroxyurea 59 Cellular Immunotherapy 59 CYT# QbG# 59 Prolongs Survival 59 Voreloxin 59 Adjuvant 59 Preclinical Models 59 Metastatic 59 Mouse Model 59 Relapsed Refractory 59 Anthracyclines 59 Tumor Microenvironment 59 Phase IIb Trial 59 Severe Sepsis 59 Tumor Necrosis Factor 59 Conjugate 59 Peginterferon 59 Gemcitabine 59 Erlotinib 59 targeted antifolate 58 Rituximab 58 PDE# 58 Cytotoxicity 58 adalimumab Humira 58 Interferon alpha 58 Chronic Lymphocytic Leukemia 58 Prostate Cancer Vaccine 58 Phase IIb Clinical Trial 58 Etanercept 58 Degarelix 58 Eculizumab 58 Complicated Skin 58 Neoadjuvant 58 Hormone Refractory Prostate Cancer 58 ALN TTR 58 Inflammatory Disease 58 Refractory Angina 58 Bevacizumab 58 Factor VIIa 58 Prophylaxis 58 Tesetaxel 58 Immunosuppression 58 Traficet EN 58 Respiratory Virus 58 CTLA4 Ig 58 Glioblastoma Multiforme 58 Cytarabine 58 Valopicitabine 58 Fulvestrant 58 Epithelial 58 Adjuvant Therapy 58 II Clinical Trial 58 Malaria Vaccine 58 prophylactic vaccine 58 Taxane 58 Dendritic Cell 58 Dalbavancin 58 Chemotherapy 58 Aflibercept 58 Adefovir 58 biologic therapy 58 DermaVir 58 novel peptide 58 imatinib Gleevec ® 58 Metastatic Prostate Cancer 58 Elagolix 58 Gout Drug 58 Neurodegenerative Disease 58 Investigational Treatment 58 Transcription Factor 58 proteasome inhibitors 58 Gene Expression 58 vascular disrupting agents 58 immunotherapeutic 58 Lenalidomide 58 Placebo Controlled Study 58 Phase 2b Study 58 Advanced Melanoma 58 Novel Oral 58 humanized anti 58 Smooth Muscle 58 Immunomodulatory 58 DFMO 58 Pralatrexate 58 Myelofibrosis 58 Liprotamase 58 DiLA2 58 Monoclonal antibody 58 Neurodegenerative Diseases 58 Demonstrates Potent 58 Immune Therapy 58 Inhaled Corticosteroids 58 Genes Involved 58 Analgesic 58 Novel Inhibitor 58 liposomal formulation 58 chimeric monoclonal antibody 58 Cytotoxic 58 sorafenib Nexavar 58 Breast Cancer Metastasis 58 LHRH antagonist 58 Improved Survival 58 Chemotherapeutic 58 Novel Approaches 58 Targeted Therapy 58 Chemoradiation 58 Proteasome 58 Oligonucleotide 58 Shows Promise Against 58 Rheumatoid Arthritis Patients 58 Fludarabine 58 Drug Resistant 58 Ridaforolimus 58 Septic Shock 58 Soft Tissue Sarcoma 58 Fixed Dose 58 therapeutic monoclonal antibody 58 Daclizumab 58 Protease Inhibitor 57 Patients Treated With 57 Angiogenic 57 alpha 2a 57 tyrosine kinase inhibitor 57 Fungal Infections 57 Laquinimod 57 Olaparib 57 AMN# [001] 57 Patients Receiving 57 EVIZON TM 57 Preclinical Data 57 Azacitidine 57 Radiofrequency Ablation 57 Anticancer Drugs 57 Gastric Cancer 57 Peripheral Blood 57 ara C 57 dasatinib Sprycel ® 57 Drug Shows Promise 57 Chronic Sinusitis 57 Improves Survival 57 NEUGENE 57 Oral Spray 57 Fluorouracil 57 immunotherapeutic vaccine 57 multi kinase inhibitor 57 metastatic malignant 57 5 Fluorouracil 57 Protein Therapeutics 57 Combination Treatment 57 Pegylated Interferon 57 Lung Cancer Trial 57 Viral Infections 57 Estrogen Receptor 57 Interferon Alpha 57 Ramoplanin 57 antisense oligonucleotides 57 Infected Patients 57 Vidofludimus 57 Pazopanib 57 dasatinib Sprycel 57 imatinib Gleevec 57 Angiogenesis 57 Allogeneic 57 investigational monoclonal antibody 57 Pathogenesis 57 cyclosporin 57 Natalizumab 57 Phase III Clinical Trial 57 ISF# 57 Cyclosporine 57 Immunogenicity 57 Polymerase Inhibitor 57 Stakeholder Opinions 57 Molecular Basis 57 Novel Therapeutics 57 Clinical Outcome 57 Mesenchymal Stem Cells 57 Campath alemtuzumab 57 Inactivated 57 Pafuramidine 57 Combination therapy 57 Vandetanib 57 Antitumor Activity 57 vorinostat 57 Innate Immune 57 Respiratory Syncytial Virus 57 alkylating agent 57 Meets Primary Endpoint 57 Cardiotoxicity 57 bortezomib Velcade 57 gastrointestinal stromal tumors GIST 57 Fingolimod 57 Efficacious 57 Squalamine 57 CCX# 57 monoclonal antibodies 57 angiogenesis inhibition 57 Monoclonal 57 proteasome inhibitor 57 Altastaph 57 Bisphosphonate 57 Pneumococcal Vaccine 57 Progenitor Cells 57 Novel Mechanism 57 immune modulatory 57 signal transduction inhibitors 57 Radiofrequency Ablation RFA 57 Initiates Clinical Trial 57 Prostacyclin 57 Therapeutic Targets 57 Nanobody 57 Lymphoid 57 Cervical Dysplasia 57 Autoimmune Disorders 57 Novel Treatments 57 JAK2 inhibitor 57 Selective Internal 57 siRNA delivery 57 Exemestane 57 Epratuzumab 57 Amphotericin B 57 Cethromycin 57 Enlarged Prostate 57 PCK# 57 Medicinal Chemistry 57 Oral Mucositis 57 Macrolide 57 Controlled Study 57 Leukemias 57 KRN# 57 Biomarker 57 Neural Stem Cells 57 Protein Interactions 57 Protease Inhibitors 57 Dapagliflozin 57 PKC# 57 immunotherapies 57 CYT# potent vascular disrupting 57 Chronic Heart Failure 57 Inactivation 57 Treatment Regimen 57 Intravenous CP 57 Retroviral 57 IAP inhibitors 57 Azedra 57 nucleoside analog 57 Sphingomab 57 OvaRex R 57 Targeted Therapies 57 OMP #R# 57 Gleevec imatinib mesylate 57 Omalizumab 57 MyVax R 57 Chemotherapeutic Agents 57 Pharmacokinetic Study 57 Antitumor activity 57 Tumor Growth 56 Antibody 56 immunoconjugate 56 Gene Therapy 56 Mitoxantrone 56 Previously Untreated 56 Symadex 56 Tarvacin 56 Newly Diagnosed 56 HuMax CD4 56 LHRH antagonists 56 Adjuvant Chemotherapy 56 small molecule tyrosine 56 Universal Influenza Vaccine 56 JAK Inhibitor 56 PNP inhibitor 56 bevacizumab Avastin 56 immunomodulators 56 Skeletal Muscle 56 Receives Orphan Drug Designation 56 Antifungal 56 Novel Antibody 56 Renal Cell Carcinoma 56 Mipomersen 56 Raltegravir 56 Pathway Inhibitor 56 Carfilzomib 56 investigational humanized monoclonal antibody 56 Gene Silencing 56 Enzyme Replacement Therapy 56 Oxidative Stress 56 Thiovir 56 Pharmacologic 56 trastuzumab Herceptin 56 Ribavirin 56 Metastatic Colorectal Cancer 56 Myelodysplastic Syndrome MDS 56 ganetespib 56 Benign Prostatic Hyperplasia 56 Nanoemulsion 56 Stem Cell Transplant 56 Neuroendocrine Tumors 56 receptor tyrosine kinase inhibitor 56 Prostate Cancer Treatment 56 targeted radiotherapeutic 56 Adenoma 56 vinca alkaloid 56 Breast Cancer Recurrence 56 Mimetics 56 Inhalation Solution 56 Bezielle 56 Hepatic Encephalopathy 56 HCV Protease Inhibitor 56 Pulmonary Arterial Hypertension 56 immunotherapeutics 56 siRNA therapeutics 56 Allergic Rhinitis 56 Myoblast 56 BRAF inhibitor 56 Previously Treated 56 Sustained Release 56 Analytical Tool 56 Efficacy Trial 56 Monotherapy 56 Litx 56 MEK inhibitors 56 Adenoviral 56 Personalised Medicine 56 Oxaliplatin 56 Alocrest 56 ixabepilone 56 OncoVEX 56 Effective Treatments 56 infliximab Remicade 56 See CLINICAL PHARMACOLOGY 56 direct thrombin inhibitors 56 superficial bladder cancer 56 Oligonucleotides 56 Lupus Nephritis 56 IRX 2 56 thalidomide Thalomid 56 meropenem 56 Single Dose 56 Phase III Trials 56 Novel Therapies 56 tyrosine kinase inhibitor TKI 56 Cancer Treatments 56 Protein Kinase 56 Vicriviroc 56 Malignant Glioma 56 Bosentan 56 Multiple Myeloma Patients 56 angiogenesis inhibitor 56 Tissue Repair 56 nucleotide analogs 56 Mantle Cell Lymphoma 56 Cell Lymphoma 56 Prognostic Factors 56 myelofibrosis polycythemia vera 56 Advanced Prostate Cancer 56 chemotherapeutic agent 56 Ozarelix 56 Anti TNF 56 orally bioavailable 56 Rotavirus Vaccine 56 Nicotine Vaccine 56 Peptide 56 siRNA Delivery 56 Effectively Treats 56 TLR9 agonist 56 Therapeutic Antibodies 56 Inflammatory Bowel Disease 56 Dendritic cell 56 Valortim R 56 Dose Escalation 56 bevacizumab Avastin ® 56 Mouse Models 56 Protein Expression 56 cidofovir 56 Clolar ® 56 chemopreventive agent 56 Anticancer Activity 56 Shows Efficacy 56 CD# antibody [001] 56 PYY #-# 56 Oncogenic 56 CCX# B 56 RAV# 56 histone deacetylase HDAC inhibitors 56 Glucocorticoid 56 Docetaxel 56 Diabetic Neuropathy 56 Treatment Naive Patients 56 Hematologic Malignancies 56 Renal Cancer 56 Clofarabine 56 Viral Infection 56 Antiviral Activity 56 Statin Therapy 56 Microplasmin 56 Allovectin 7 56 antiviral therapies 56 photodynamic therapy 56 VEGF inhibitors 56 Maribavir 56 BiTE Antibody 56 sunitinib Sutent ® 56 Pemetrexed 56 HQK 56 IMA# 56 Slows Progression 56 Stapled Peptide 56 Kinoid 56 dexamethasone Decadron 56 HuLuc# 56 Overactive Bladder 56 Immunosuppressive 56 Autologous Stem Cell Transplantation 56 Long Term Efficacy 56 Signaling Pathway 56 Novel Vaccine 56 Tuberculosis Vaccine 56 Novel Small Molecule 56 Respiratory Syncytial Virus RSV 56 Lamotrigine 56 antiviral therapy 56 Inflammatory Markers 56 Everolimus 56 Patient Enrollment 56 cetuximab Erbitux R 56 Solid Tumors 56 Migraine Treatment 56 Treated Patients 56 intratumoral injection 56 flavopiridol 56 erlotinib Tarceva ® 56 Phase Ib Clinical Trial 56 Anti angiogenic 56 Adjuvanted 56 Orally Active 55 paclitaxel Taxol 55 live attenuated vaccines 55 Nuclear Receptors 55 Advanced Renal Cell 55 Neuroinflammation 55 Cytomegalovirus 55 Phase 2a Trial 55 Heart Failure Patients 55 Preclinical Development 55 Beta Blocker 55 Tumor Progression 55 Treatment Reduces 55 Inhibits Growth 55 Rasagiline 55 Breast Cancer Cells 55 Nitazoxanide 55 Neulasta ® 55 Vaccine Shows Promise 55 Doxorubicin 55 Infliximab 55 mapatumumab 55 Pulmonary Hypertension 55 Rilonacept 55 Neurochemistry 55 alefacept 55 ARRY # 55 Anticancer Drug 55 molecularly targeted therapies 55 RNA Therapeutics 55 Urinary Incontinence 55 poly ADP ribose polymerase 55 Dengue Virus 55 epigenetic therapies 55 JAK1 55 Combination REOLYSIN R 55 Carboplatin 55 Genital Herpes 55 Enoxaparin 55 protein kinase inhibitors 55 Hematological Malignancies 55 RhuDex 55 PDE4 inhibitor 55 BAL# [001] 55 OHR/AVR# 55 Stem Cell Treatment 55 Metastatic Renal Cell Carcinoma 55 Presents Preclinical Data 55 humanized monoclonal 55 Sorafenib 55 Preclinical Study 55 Cytokine 55 Recombinant Protein 55 Bucindolol 55 Oncologic 55 Pharmacodynamics 55 DepoVax 55 Gastrointestinal Cancers 55 Retrovirus 55 Lung Cancer Drug 55 Japanese Encephalitis vaccine 55 Xanafide 55 VitiGam 55 Paclitaxel 55 L BLP# 55 Biological Therapy 55 Demonstrates Sustained 55 Cell Differentiation 55 Novosom 55 Chronic Rhinosinusitis 55 Randomized Study 55 humanized antibody 55 Entry Inhibitor 55 Drug Pipeline 55 IND Application 55 Therapy Shows Promise 55 gamma secretase inhibitors 55 Inhaled nitric oxide 55 Ceflatonin R 55 Therapeutic Efficacy 55 Liver Metastases 55 Intravail ® 55 Kidney Transplant Patients 55 Initiate Clinical Trial 55 MEK Inhibitor 55 BRAF inhibitors 55 Pharmacological 55 Progenitor Cell 55 leukemia AML 55 Taxanes 55 MKC# MKC# PP 55 Chronic Myelogenous Leukemia 55 Plaque Psoriasis 55 Zolinza 55 Recombinant Human 55 Mycophenolate Mofetil 55 Homspera TM 55 CYC# 55 Belldegrun 55 Appears Safe 55 DepoVax TM 55 immunomodulatory agents 55 immunosuppressant drug 55 Pivotal Phase 55 Investigational Drug 55 Velcade bortezomib 55 Biosimilar 55 DermaVir Patch 55 HDL Selective Delipidation 55 lapatinib Tykerb 55 BiTE 55 Drug Discovery 55 Panzem 55 Anticancer Agent 55 NS#/#A protease 55 Cytometry 55 PEGylated interferon 55 Lung Cancer Patients 55 histone deacetylase inhibitors 55 Vaccine Protects Against 55 Clinical Efficacy 55 Signal Transduction 55 Rheumatoid Arthritis Drug 55 anti CD3 55 Pharmacokinetics 55 TAFA# 55 radezolid 55 immunotherapeutic agent 55 Patent Covering 55 Antimalarial 55 Endothelial 55 Allosteric 55 Tocilizumab 55 immune modulating 55 AKT inhibitor 55 Adjunctive Therapy 55 Topotecan 55 antibody MAb 55 Neural Stem Cell 55 Therapy Evaluation 55 anti CD# antibodies 55 Induction Therapy 55 integrase inhibitors 55 Cell Transplant 55 molecularly targeted 55 Metastatic Disease 55 Curaxin CBLC# 55 Cancer Vaccine 55 Brain Tumor Therapy 55 immune modulation 55 peptide antigens 55 Progressive Multifocal Leukoencephalopathy 55 Cancer Stem Cells 55 Diabetic Foot Ulcer 55 Relapsing Remitting Multiple Sclerosis 55 therapeutic monoclonal antibodies 55 Bioral ® 55 neuroprotection 55 Antibody Drug Conjugate 55 Tolamba 55 Revimmune 55 OncoVEX GM CSF 55 Merck Wyeth Vical 55 Plasmid DNA 55 Tissue Engineering 55 Scancell 55 Sym# 55 Receptor Antagonists 55 chemopreventive agents 55 Drug Combo 55 Myelodysplastic Syndrome 55 histone deacetylase inhibitor 55 Abiraterone acetate 55 Cancer Therapeutics 55 Neutralizing Antibodies 55 cancer immunotherapies 55 Cabazitaxel 55 docetaxel Taxotere ® 55 therapeutics 55 denileukin diftitox 55 Investigational Agent 55 Combination Therapies 55 monoclonal antibody 55 Potent Anti 55 TTR amyloidosis 55 systemic RNAi therapeutic 55 Severe Asthma 55 Alfacell proprietary ribonuclease 55 inhibits protein synthesis 55 Noxafil 55 Subunit 55 Embolization 55 MT#/MEDI-# 55 milatuzumab 55 Hematopoietic 55 adenoviral 55 Trial Evaluating 55 Oral Insulin 55 Carcinoma 55 Late Breaker 55 Cinacalcet 55 Post Operative 55 Moxifloxacin 55 antisense inhibitor 55 chemotherapeutics 55 Proves Effective 55 AEG# 55 Improve Survival 55 Antitumor 55 Glatiramer Acetate 55 Cell Signaling 55 Cetuximab 55 anti CD3 antibody 55 Hypercholesterolemia 54 Cyclosporin 54 Neoplasms 54 tiapamil 54 Fibrosis 54 vivo validation 54 PARP inhibitors 54 Stomach Cancer 54 Study Evaluating 54 Neuroimmunology 54 anticancer agent 54 Postmenopausal Women 54 IMiDs ® 54 Clinical Trial Evaluating 54 Dupuytren Contracture 54 Panzem R 54 tumor antigen 54 monoclonal antibody MAb 54 HER2 Positive Breast Cancer 54 HCV protease inhibitors 54 Protein Linked 54 ATG Fresenius S 54 Juvenile Idiopathic Arthritis 54 Pemphigus 54 Methotrexate 54 Prostate Cancer Patients 54 selective kinase inhibitor 54 antitumor 54 Cell Proliferation 54 enzastaurin 54 Somatostatin 54 histone deacetylase HDAC inhibitor 54 Cell Adhesion 54 Acute Stroke 54 relapsing multiple sclerosis 54 Hormone Receptor Positive 54 exon skipping 54 Nanobody ® 54 Bevacizumab Avastin 54 tigecycline 54 tenofovir Viread 54 Inhaled Nitric Oxide 54 Vorinostat 54 Allovectin 7 R 54 antiangiogenic agents 54 Alferon N 54 Anti Angiogenic 54 Hepatitis B Vaccine 54 NABTT 54 DCVax R 54 Pivotal Study 54 Anticoagulant 54 gefitinib Iressa 54 Ceflatonin 54 Randomized Phase 54 Prophylactic Treatment 54 Regado Biosciences 54 Protexia R 54 Cannabinoid 54 Transdermal Drug 54 rxRNA 54 TroVax ® 54 Fluconazole 54 M2 subunit 54 Prodarsan R 54 pegylated 54 Celecoxib 54 Fondaparinux 54 Cloretazine ® 54 Tiotropium 54 poliovirus vaccine 54 pertuzumab 54 radionuclide therapy 54 Drug Prevents 54 Genetic Variation 54 Disease Modifying 54 Anti Angiogenesis 54 FDA Accepts 54 Solid Tumor 54 Thyroid Hormone 54 Left Atrial 54 Prodrug 54 TG# [001] 54 eniluracil 54 HER2 Positive 54 Phase IIb clinical trials 54 ChronVac C R 54 InNexus Biotechnology 54 recurrent glioblastoma multiforme 54 Intracellular 54 Pivotal Phase III 54 Interferon beta 54 Inhibitors 54 nucleoside analogues 54 Squamous Cell Carcinoma 54 Blood Pressure Drug 54 EGFR inhibitors 54 Acute Ischemic Stroke 54 Virulizin ® 54 Peginterferon Alfa 2b 54 Autoimmune 54 Seasonal Influenza Vaccine 54 daptomycin 54 vinca alkaloids 54 Bone Marrow Transplants 54 Rotigotine 54 Protease 54 Vidaza azacitidine 54 CDDO Im 54 humanised monoclonal antibody 54 Inhibits 54 Treatment Shows Promise 54 Bronchodilator 54 Glioblastoma 54 Pandemic Influenza Vaccine 54 SGLT2 inhibitors 54 recombinant subunit vaccine 54 ALN PCS 54 Kidney Function 54 Surgical Treatment 54 Photodynamic Therapy 54 Ataluren 54 Improves Outcomes 54 PARP inhibitor 54 Molecular Mechanisms 54 Tacrolimus 54 novel immunotherapeutic 54 Tigecycline 54 Peripheral Arterial 54 Hospital Acquired Pneumonia 54 Cytomegalovirus CMV 54 Regenerative Cells 54 luteinizing hormone releasing 54 reverse vaccinology 54 trimethoprim sulfamethoxazole 54 taxol 54 antiangiogenesis 54 Initiates Clinical 54 Potent Antiviral Activity 54 Transdermal Patch 54 Torisel 54 Knee Osteoarthritis 54 ASONEP 54 PSMA ADC 54 Epstein Barr Virus 54 protein kinase inhibitor 54 Phospholipase A2 54 Antiretroviral 54 Linezolid 54 Therapeutic Agents 54 CTAP# Capsules 54 ASH Annual Meeting 54 Adjunctive 54 Boceprevir 54 Anticancer 54 Completes Patient Enrollment 54 Camptosar ® irinotecan 54 Naive Patients 54 Antibiotic Resistant 54 Pirfenidone 54 MEK inhibitor 54 Pivotal Trial 54 Lung Cancer Survival 54 recurrent glioma 54 Systemic Sclerosis 54 Zinc Finger Nuclease 54 Vasculitis 54 Insulin Resistance 54 VZV 54 Emerging Therapies 54 immunomodulator 54 Interferons 54 IMGN# 54 Pancreatic 54 Present Preclinical Data 54 vascular disrupting agent 54 Tesamorelin 54 Myeloma Patients 54 RNAi therapeutic targeting 54 Curaxin 54 CR# vcMMAE 54 phase IIb clinical 54 Rheumatoid 54 Cloretazine VNP#M 54 Signaling Pathways 54 Oral Calcitonin 54 Muraglitazar 54 gene therapy 54 Gastrointestinal Disorders 54 Tumor Targeted 54 enzyme inhibitor 54 Zoledronic acid 54 Transfection Reagent 54 rituximab Rituxan 54 Bone Metastases 54 vidofludimus 54 triphendiol 54 Anti VEGF 54 Breast Cancer Treatment 54 gemcitabine Gemzar ® 54 Elderly Patients 54 Lisofylline 54 Influenza Vaccine 54 Zybrestat 54 Hsp# inhibition 54 protein tyrosine phosphatase 1B 54 Immunologic